Blind prediction performance of RosettaAntibody 3.0: Grafting, relaxation, kinematic loop modeling, and full CDR optimization

Proteins: Structure, Function and Bioinformatics

Volumn 82, Issue 8, 2014, Pages 1611-1623

  Weitzner, Brian D ^a   Kuroda, Daisuke ^a   Marze, Nicholas ^a   Xu, Jianqing ^a   Gray, Jeffrey J ^a,b  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Antigen binding site; Canonical structures; Homology modeling; Immunoglobulin; Loop prediction; Rosetta

Indexed keywords

ACCURACY; ANTIBODY COMBINING SITE; ANTIBODY STRUCTURE; ARTICLE; CARBOXY TERMINAL SEQUENCE; KINEMATICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN CONFORMATION; ALGORITHM; ANIMAL; BIOMECHANICS; CHEMICAL STRUCTURE; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; COMPUTER PROGRAM; HUMAN;

COMPLEMENTARITY DETERMINING REGION; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ALGORITHMS; ANIMALS; BIOMECHANICAL PHENOMENA; COMPLEMENTARITY DETERMINING REGIONS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULINS; MODELS, MOLECULAR; PROTEIN CONFORMATION; SOFTWARE;

EID: 84904468725     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24534     Document Type: Article

References (76)

1. Buss NA, Henderson SJ, McFarlane M, Shenton JM, de Haan L. Monoclonal antibody therapeutics: history and future. Curr Opin Pharmacol 2012;12:615-622.
2. Reichert JM. Antibodies to watch in 2014. MAbs 2014;6:0-1.
3. Lippow SM, Wittrup KD, Tidor B. Computational design of antibody-affinity improvement beyond in vivo maturation. Nat Biotechnol 2007;25:1171-1176.
4. Farady CJ, Sellers BD, Jacobson MP, Craik CS. Improving the species cross-reactivity of an antibody using computational design. Bioorg Med Chem Lett 2009;19:3744-3747.
5. Clark LA, Boriack-Sjodin PA, Eldredge J, Fitch C, Friedman B, Hanf KJ, Jarpe M, Liparoto SF, Li Y, Lugovskoy A, Miller S, Rushe M, Sherman W, Simon K, Van Vlijmen H. Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design. Protein Sci 2006;15:949-960.
6. Barderas R, Desmet J, Timmerman P, Meloen R, Casal JI. Affinity maturation of antibodies assisted by in silico modeling. Proc Natl Acad Sci USA 2008;105:9029-9034.
7. Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. Design of therapeutic proteins with enhanced stability. Proc Natl Acad Sci USA 2009;106:11937-11942.
8. Miklos AE, Kluwe C, Der BS, Pai S, Sircar A, Hughes RA, Berrondo M, Xu J, Codrea V, Buckley PE, Calm AM, Welsh HS, Warner CR, Zacharko MA, Carney JP, Gray JJ, Georgiou G, Kuhlman B, Ellington AD. Structure-based design of supercharged, highly thermoresistant antibodies. Chem Biol 2012;19:449-455.
9. Voynov V, Chennamsetty N, Kayser V, Helk B, Trout BL. Predictive tools for stabilization of therapeutic proteins. MAbs 2009;1:580-582.
10. Chennamsetty N, Voynov V, Kayser V, Helk B, Trout BL. Prediction of aggregation prone regions of therapeutic proteins. J Phys Chem B 2010;114:6614-6624.
11. Lauer TM, Agrawal NJ, Chennamsetty N, Egodage K, Helk B, Trout BL. Developability index: A rapid in silico tool for the screening of antibody aggregation propensity. J Pharm Sci 2012;101:102-115.
12. Kuroda D, Shirai H, Jacobson MP, Nakamura H. Computer-aided antibody design. Protein Eng Des Sel 2012;25:507-521.
13. Chothia C, Gelfand I, Kister A. Structural determinants in the sequences of immunoglobulin variable domain. J Mol Biol 1998;278:457-479.
14. Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ. Conformations of immunoglobulin hypervariable regions. Nature 1989;342:877-883.
15. Tramontano A, Chothia C, Lesk AM. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins. J Mol Biol 1990;215:175-182.
16. Shirai H, Kidera A, Nakamura H. Structural classification of CDR-H3 in antibodies. FEBS Lett 1996;399:1-8.
17. Shirai H, Nakajima N, Higo J, Kidera A, Nakamura H. Conformational sampling of CDR-H3 in antibodies by multicanonical molecular dynamics simulation. J Mol Biol 1998;278:481-496.
18. Al-Lazikani B, Lesk AM, Chothia C. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 1997;273:927-948.
19. Morea V, Tramontano A, Rustici M, Chothia C, Lesk AM. Conformations of the third hypervariable region in the VH domain of immunoglobulins. J Mol Biol 1998;275:269-294.
20. Furukawa K, Akasako-Furukawa A, Shirai H, Nakamura H, Azuma T. Junctional amino acids determine the maturation pathway of an antibody. Immunity 1999;11:329-338.
21. Bond CJ, Marsters JC, Sidhu SS. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries. J Mol Biol 2003;332:643-655.
22. Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA, Schroeder HW, Jr, Kirkham PM. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol 2003;334:733-749.
23. Kuroda D, Shirai H, Kobori M, Nakamura H. Structural classification of CDR-H3 revisited: a lesson in antibody modeling. Proteins 2008;73:608-620.
24. Kuroda D, Shirai H, Kobori M, Nakamura H. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface. Proteins 2009;75:139-146.
25. Sellers BD, Nilmeier JP, Jacobson MP. Antibodies as a model system for comparative model refinement. Proteins 2010;78:2490-2505.
26. North B, Lehmann A, Dunbrack RL, Jr. A new clustering of antibody CDR loop conformations. J Mol Biol 2011;406:228-256.
27. Persson H, Ye W, Wernimont A, Adams JJ, Koide A, Koide S, Lam R, Sidhu SS. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies. J Mol Biol 2013;425:803-811.
28. MacCallum RM, Martin AC, Thornton JM. Antibody-antigen interactions: contact analysis and binding site topography. J Mol Biol 1996;262:732-745.
29. Collis AV, Brouwer AP, Martin AC. Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen. J Mol Biol 2003;325:337-354.
30. Lee M, Lloyd P, Zhang X, Schallhorn JM, Sugimoto K, Leach AG, Sapiro G, Houk KN. Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification scheme. J Org Chem 2006;71:5082-5092.
31. Soga S, Kuroda D, Shirai H, Kobori M, Hirayama N. Use of amino acid composition to predict epitope residues of individual antibodies. Protein Eng Des Sel 2010;23:441-448.
32. Sela-Culang I, Alon S, Ofran Y. A systematic comparison of free and bound antibodies reveals binding-related conformational changes. J Immunol 2012;189:4890-4899.
33. Raghunathan G, Smart J, Williams J, Almagro JC. Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens. J Mol Recognit 2012;25:103-113.
34. Kunik V, Ofran Y. The indistinguishability of epitopes from protein surface is explained by the distinct binding preferences of each of the six antigen-binding loops. Protein Eng Des Sel 2013;26:599-609.
35. Ramaraj T, Angel T, Dratz EA, Jesaitis AJ, Mumey B. Antigen-antibody interface properties: composition, residue interactions, and features of 53 non-redundant structures. Biochim Biophys Acta 2012;1824:520-532.
36. Stave JW, Lindpaintner K. Antibody and antigen contact residues define epitope and paratope size and structure. J Immunol 2013;191:1428-1435.
37. Olimpieri PP, Chailyan A, Tramontano A, Marcatili P. Prediction of site-specific interactions in antibody-antigen complexes: the proABC method and server. Bioinformatics 2013;29:2285-2291.
38. Marcatili P, Rosi A, Tramontano A. PIGS: automatic prediction of antibody structures. Bioinformatics 2008;24:1953-1954.
39. Sircar A, Kim ET, Gray JJ. RosettaAntibody: antibody variable region homology modeling server. Nucleic acids research 2009;37(Web Server issue):W474-W479.
40. Whitelegg NR, Rees AR. WAM: an improved algorithm for modelling antibodies on the WEB. Protein Eng 2000;13:819-824.
41. Almagro JC, Beavers MP, Hernandez-Guzman F, Maier J, Shaulsky J, Butenhof K, Labute P, Thorsteinson N, Kelly K, Teplyakov A, Luo J, Sweet R, Gilliland GL. Antibody modeling assessment. Proteins 2011;79:3050-3066.
42. Dunbar J, Krawczyk K, Leem J, Baker T, Fuchs A, Georges G, Shi J, Deane CM. SAbDab: the structural antibody database. Nucleic Acids Res 2013;42:D1140-D1146.
43. Dunbar J, Fuchs A, Shi J, Deane CM. ABangle: characterising the VH-VL orientation in antibodies. Protein Eng Des Sel 2013;26:611-620.
44. Xu J, Tack D, Hughes RA, Ellington AD, Gray JJ. Structure-based non-canonical amino acid design to covalently crosslink an antibody-antigen complex. J Struct Biol 2013;185:215-222.
45. Zhao S, Zhu K, Li J, Friesner RA. Progress in super long loop prediction. Proteins 2011;79:2920-2935.
46. Mandell DJ, Coutsias EA, Kortemme T. Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling. Nat Methods 2009;6:551-552.
47. Stein A, Kortemme T. Improvements to robotics-inspired conformational sampling in rosetta. PLoS One 2013;8:e63090.
48. Das R. Atomic-accuracy prediction of protein loop structures through an RNA-inspired ansatz. PLoS One 2013;8:e74830.
49. Leaver-Fay A, Tyka M, Lewis SM, Lange OF, Thompson J, Jacak R, Kaufman K, Renfrew PD, Smith CA, Sheffler W, Davis IW, Cooper S, Treuille A, Mandell DJ, Richter F, Ban YE, Fleishman SJ, Corn JE, Kim DE, Lyskov S, Berrondo M, Mentzer S, Popovic Z, Havranek JJ, Karanicolas J, Das R, Meiler J, Kortemme T, Gray JJ, Kuhlman B, Baker D, Bradley P. ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol 2011;487:545-574.
50. Chen VB, Arendall WB, 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010;66(Pt 1):12-21.
51. Chaudhury S, Berrondo M, Weitzner BD, Muthu P, Bergman H, Gray JJ. Benchmarking and analysis of protein docking performance in Rosetta v3.2. PLoS One 2011;6:e22477.
52. Abhinandan KR, Martin AC. Analysis and prediction of VH/VL packing in antibodies. Protein Eng Des Sel 2010;23:689-697.
53. McLachlan A. Rapid comparison of protein structures. Acta Crystallogr A 1982;38:871-873.
54. Martin ACR, Porter CT. Available at: http://www.bioinf.org.uk/software/profit/.
55. Sivasubramanian A, Sircar A, Chaudhury S, Gray JJ. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins 2009;74:497-514.
56. Whitelegg N, Rees AR. Antibody variable regions: toward a unified modeling method. Methods Mol Biol 2004;248:51-91.
57. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000;28:235-242.
58. Berman H, Henrick K, Nakamura H. Announcing the worldwide Protein Data Bank. Nat Struct Biol 2003;10:980.
59. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-410.
60. Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987;196:901-917.
61. Almagro JC, Fransson J. Humanization of antibodies. Front Biosci 2008;13:1619-1633.
62. Engh RA, Huber R. Accurate bond and angle parameters for X-ray protein-structure refinement. Acta Crystallogr A 1991;47:392-400.
63. Nivon LG, Moretti R, Baker D. A Pareto-optimal refinement method for protein design scaffolds. PLoS One 2013;8:e59004.
64. Canutescu AA, Dunbrack RL, Jr. Cyclic coordinate descent: A robotics algorithm for protein loop closure. Protein Sci 2003;12:963-972.
65. Rohl CA, Strauss CE, Chivian D, Baker D. Modeling structurally variable regions in homologous proteins with rosetta. Proteins 2004;55:656-677.
66. Ting D, Wang G, Shapovalov M, Mitra R, Jordan MI, Dunbrack RL, Jr. Neighbor-dependent Ramachandran probability distributions of amino acids developed from a hierarchical dirichlet process model. PLoS Comput Biol 2010;6:e1000763.
67. Berkholz DS, Driggers CM, Shapovalov MV, Dunbrack RL, Karplus PA. Nonplanar peptide bonds in proteins are common and conserved but not biased toward active sites. Proc Natl Acad Sci USA 2012;109:449-453.
68. Chailyan A, Marcatili P, Cirillo D, Tramontano A. Structural repertoire of immunoglobulin lambda light chains. Proteins 2011;79:1513-1524.
69. Abhinandan KR, Martin AC. Analyzing the "degree of humanness" of antibody sequences. J Mol Biol 2007;369:852-862.
70. Chaudhury S, Gray JJ. Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles. J Mol Biol 2008;381:1068-1087.
71. Sircar A, Gray JJ. SnugDock: paratope structural optimization during antibody-antigen docking compensates for errors in antibody homology models. PLoS Comput Biol 2010;6:e1000644.
72. Davey JA, Chica RA. Multistate approaches in computational protein design. Protein science : a publication of the Protein Society 2012;21:1241-1252.
73. Totrov M, Abagyan R. Flexible ligand docking to multiple receptor conformations: a practical alternative. Curr Opin Struct Biol 2008;18:178-184.
74. C B Rao, Subramanian J, Sharma SD. Managing protein flexibility in docking and its applications. Drug Discov Today 2009;14:394-400.
75. Lyskov S, Chou FC, Conchuir SO, Der BS, Drew K, Kuroda D, Xu J, Weitzner BD, Renfrew PD, Sripakdeevong P, Borgo B, Havranek JJ, Kuhlman B, Kortemme T, Bonneau R, Gray JJ, Das R. Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE). PLoS One 2013;8:e63906.
76. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605-1612.